Nav: Home

Antimicrobial "Bug Spray" Found In Human Lung Cells

June 18, 1997

Hopkins scientists studying lung damage from cystic fibrosis (CF) have found a natural "bug spray" that lung cells "squirt" on attacking bacteria.

The "spray", an antimicrobial compound researchers call hTAP(human tracheal antimicrobial peptide), appears to be disabled in CF patients, increasing their vulnerability to lung infections. If researchers can mass-produce hTAP or similar compounds, they may help fight lung infections in both CF patients and in the general population, where infectious lung diseases like tuberculosis kill more than 7 million people every year.

"People have always thought that the lungs only attacked infections via the classical immune system--B cells, T cells and other immune cells," says Pete Pedersen, Ph.D., Hopkins professor of biological chemistry. "But lung cells apparently have their own first-line defense mechanism--they shoot out one or more peptides that kill bacteria."

After the first such compounds were identified in cells from frog skin and cow throats by researchers at other institutions Young Hee Ko, a research associate in Pedersen's lab, suspected that CF jammed the "nozzle" on a similar bug spray.

"That nozzle is a channel on the surface of lung cells called CFTR, and we already knew that CF disrupts it," says Ko.

In a study funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the Cystic Fibrosis Foundation, Ko exposed two batches of lung cells, one from a normal patient and one from a CF patient, to Pseudomonas aeruginosa, a bacterium that causes repeated lung infections in CF patients.

The bacteria infected many CF cells while making little progress in the normal cells. Ko then searched for an antimicrobial compound similar to the one found in cow throats, and found hTAP.

Pedersen speculates that cells in other areas at high risk for infection, such as the eyes, the gut or the mouth, may secrete similar germ-fighting compounds.

Their results were published recently in the journal FEBS (Federation of European Biochemical Societies) Letters. The other study author was Michael Delannoy, an electron microscopist.

###




Johns Hopkins Medicine

Related Cystic Fibrosis Articles:

New treatment kills off infection that can be deadly to cystic fibrosis patients
The findings, which are published in the journal Scientific Reports, show that scientists from Aston University, Mycobacterial Research Group, combined doses of three antibiotics -- amoxicillin and imipenem-relebactam and found it was 100% effective in killing off the infection which is usually extremely difficult to treat in patients with cystic fibrosis.
Cystic fibrosis carriers are at increased risk for cystic fibrosis-related conditions
A University of Iowa study challenges the conventional wisdom that having just one mutated copy of the cystic fibrosis (CF) gene has no effects on a person's health.
Modifier gene may explain why some with cystic fibrosis are less prone to infection
People with cystic fibrosis who carry genetic variants that lower RNF5 gene expression have more mutant CFTR protein on cell surfaces.
Rare mutations drive cystic fibrosis in Caribbean
Cystic Fibrosis (CF) in the Caribbean is dominated by unusual gene mutations not often observed in previously studied CF populations, according to comprehensive genome sequencing led by physician-scientists at UC San Francisco and Centro de Neumología Pediátrica in San Juan.
Cystic fibrosis carriers at increased risk of digestive symptoms
Researchers have found that carriers of the most common genetic variant that causes cystic fibrosis experience some symptoms similar to those of people with cystic fibrosis.
In cystic fibrosis, lungs feed deadly bacteria
A steady supply of its favorite food helps a deadly bacterium thrive in the lungs of people with cystic fibrosis, according to a new study by Columbia researchers.
Cibio knocks out cystic fibrosis
The fight against cystic fibrosis continues, targeting in particular some of the mutations that cause it.
Hypertonic saline may help babies with cystic fibrosis breathe better
Babies with cystic fibrosis may breathe better by inhaling hypertonic saline, according to a randomized controlled trial conducted in Germany and published in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Understanding antibiotic resistance in patients with cystic fibrosis
Patients with cystic fibrosis who carried antibiotic-resistant bacteria in their lungs had significantly lower microbial diversity and more aggressive disease, according to a small study published in Heliyon.
Discovery gives cystic fibrosis researchers new direction
A multi-disciplinary team of researchers at the Novartis Institutes for BioMedical Research (NIBR) and Harvard Medical School (HMS) started out trying to catalogue all the different cells in the airway and the paths they take to become those cells.
More Cystic Fibrosis News and Cystic Fibrosis Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.